Haemostatix

A derivative of PeproStat that is resistant to terminal sterilisation in liquid form, enabling the development of a ready-to-use, transparent flowable gel.

A flowable gel-based haemostat applied with a syringe and nozzle for less accessible wounds and wounds with uneven surfaces, composed of a heat-stable peptide active substance mixed with a transparent particulate gel.

PeproStat is a topical coagulant or haemostat applied directly to a wound during surgery to control bleeding by polymerising fibrinogen into a fibrin-like clot without the need for thrombin.

A second prototype where the GPRP sequence is protected by a thrombin-cleavable peptide component, exposing the sequence only at a wound site in the presence of thrombin.

An experimental prototype systemic platelet substitute technology consisting of microparticles linked to a fibrinogen-binding peptide sequence.